All Discovery Content

Bringing you the latest research in Drug Discovery In New Modalities, Integration Of DEL, Covalent Inhibitors, Protein Degradation Technologies, Computational Drug Design & Automation Strategies and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Commentary
A Senior Director at AstraZeneca takes us through how the company synthesises and validates novel PROTACs.
By Tom Cohen |
13 May 2022
Targeted Protein Degradation
Insight Article
Oxford Global’s protein degradation panel discussion brought together leading experts in the field to talk about bringing PROTACs to clinical trial endpoints.
By Tom Cohen |
21 April 2022
Targeted Protein Degradation
Discussion Group Report
Progress in protein degradation has accelerated in the past few years, and 2021 saw several breakthroughs. Efforts to target STAT3, however, have proven to be especially challenging.
By Oliver Picken |
18 February 2022
Targeted Protein Degradation
Insight Article
During Discovery Week 2021, Ian Churcher (Chief Scientific Officer at Amphista Therapeutics Limited) gave a fascinating presentation on recent advancements and novel approaches in protein degradation. This article provides a condensed overview of the key topics covered.
By Oliver Picken |
04 February 2022
Targeted Protein Degradation
Video Content
Video Q&A
Video Interview | Dave Madge, Vice President, Research Service Division, Wuxi Apptec
22 June 2021
Targeted Protein Degradation
Video Content
Video Q&A
In Conversation with... Sandra Stefanovic-Barrett, Senior Research Scientist, Discovery Biology, Discovery Sciences, Cellular Assay Development, AstraZeneca Yue Xiong, Cheif Scientific Officer, Cullgen
09 March 2021
Targeted Protein Degradation
Video Content
Webinar
Chairman Opening & Remarks by Danette Daniels, PHD, R&D Group Leader of Functional Proteomics, Promega Corp.
Hosted by Kristin Riching, Senior Scientist, Promega & William Farnaby, Team Leader In Medicinal Chemistry And Chemical Biology, University of Dundee
17 June 2020
Targeted Protein Degradation
Written Q&A
Michael Plewe, Vice President, Medicinal Chemistry, Cullgen Inc.
02 January 2020
Targeted Protein Degradation

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login